Jyoti Nangalia, MBBChir, on MPN: A New Paradigm for the Development of Blood Cancer?

December 08, 2020 By The ASCO Post Staff

Jyoti Nangalia, MBBChir, of Wellcome Sanger Institute and the University of Cambridge, discusses how her team used large-scale whole-genome sequencing to precisely time the origins of a blood cancer­­­­­ and measure how it grew. The information could provide opportunities for early diagnosis and intervention (Abstract LBA-1).

Related Content